medline.ch Onkologie Urologische Tumoren

	Optimal MRI sequence for predicting extraprostatic extension in prostate cancer: comparison of LCC and MaxRADD measurements. Abdom Radiol (NY) Ilanjian G, Matthey J, Porões F, Valerio M, Richemond A, Dagher J, Rakauskas A, Dromain C, Jreige M, Vietti-Violi N. PMID: 42340465 [PubMed - as supplied by publisher]
	Correction: Assessment of radiotherapy effect and toxicity using tissue-associated DNA methylation markers in cell-free DNA: a study on prostate cancer. Radiat Environ Biophys Bahtiyar N, Mermut O, Firtina S, Ozaydin A, Suleymanova A, Isikgil B, Onaran . PMID: 42340384 [PubMed - as supplied by publisher]
	A Practical Guide to PSMA PET Radiopharmaceuticals for Prostate Cancer Imaging, From the AJR Special Series on Molecular Imaging. AJR Am J Roentgenol Peacock JG, Franquet-Elia E, Harris AL, Weeks JG, Kuo PH. PMID: 42340235 [PubMed - as supplied by publisher]
	Magnetic resonance imaging radiomic phenotypes stratify response and define immune states in very high-risk, nonmuscle-invasive bladder cancer treated with tislelizumab plus nanoparticle albumin-bound paclitaxel. Cancer Huang S, Jia K, Liang S, Ma B, Chen H, Zhang Z, Kang N, Wu Z, Lin Y, Li P, Xue Z, Chen H, Zhao Y, Guo J, Li C, Chai W, Cui J, Xu G, Qie Y, Shen C, Hu H. PMID: 42339693 [PubMed - indexed for MEDLINE]
	Diagnostic Value of Spectral CT-Derived Extracellular Volume Fraction in the Early Detection of Sigmoid Colon Metastasis from Bladder Cancer: A Case Report. Surg Case Rep Peng M, Shen L, Song D, Wen L, Xiang Y, Song L. PMID: 42339343 [PubMed]
	Papillary Renal Neoplasm with Reversed Polarity in a 64-Year-Old Male: A Rare Case Report and Review of the Literature. Int Med Case Rep J Wang Y, Zhang M, Su G, Zhou Q. PMID: 42339132 [PubMed]
	Exploring the molecular link between arecoline exposure and prostate cancer-related alterations: integrative evidence from network toxicology, single-cell transcriptomics, molecular simulation, and experimental validation. Front Pharmacol Zhu X, Liu H, Zeng Z, Zou L, Zhou Y, Zhou T. PMID: 42338969 [PubMed]
	Multi-omics analysis of kidney renal cell carcinoma in silico with preliminary in vivo validation. Front Immunol Su T, Jiang F, Gao J, Li X, Cheng H, Wang Y. PMID: 42338588 [PubMed - indexed for MEDLINE]
	Dual-scan conformal cone-beam CT for targeted image-quality improvement using dynamic collimation. J Appl Clin Med Phys Liu Y, Yuan S, Feng X, Dai J. PMID: 42338073 [PubMed - indexed for MEDLINE]
	The feasibility of [(18)F]PSMA-1007 PET/CT for response assessment in prostate cancer following neoadjuvant androgen deprivation therapy compared with mpMRI. Cancer Imaging Cho S, Seo HJ, Han H, Lee S, Jeon TJ, Oh YT, Jung M, Yun M. PMID: 42337687 [PubMed - as supplied by publisher]
	Identification of alpha1-oleate as a potent regulator of adipokine-dependent metabolism, in bladder cancer tissue. Cancer Metab Haq F, Chinchankar S, Ambite I, Ahmadi S, Tran H, Nazari A, Brisuda A, Hacek J, Babjuk M, Svanborg C. PMID: 42337683 [PubMed]
	Multi-omics integration and clinical validation identify CKAP2 as a diagnostic biomarker for bladder cancer. World J Surg Oncol Li X, Yang J, Cha J, Xie H, Dong C, Yang Y, Li Y, Guo J, Lin C. PMID: 42337544 [PubMed - as supplied by publisher]
	Pro-neuropeptide Y as a circulating biomarker for poor prognosis in prostate cancer. Sci Rep Djusberg E, Lundquist K, Lundholm M, Josefsson A, Karlsson CT, Schwenk JM, Brattsand M, Bergh A, Wikström P. PMID: 42337319 [PubMed - indexed for MEDLINE]
	Multifactorial diagnostic model combining SAT-PCA3 in prostate cancer. Discov Oncol Luo Z, Dai S, Jin J, Xie W, Lei S, He Y. PMID: 42337216 [PubMed - as supplied by publisher]
	Front-line chemo-immunotherapy for advanced penile cancer: ready for prime time? Br J Cancer Thomas Z, Pettaway CA, Alhalabi O, Campbell MT, Johns AC. PMID: 42337045 [PubMed - as supplied by publisher]
	How will PLUDO, PSMAfore, SPLASH, and ECLIPSE Impact Prostate Cancer Management? Eur Urol Focus Beauregard JM, Ong M, Pouliot F. PMID: 42336749 [PubMed - as supplied by publisher]
	Re: Multicenter, Randomized, Phase II Trial of Olaparib Plus Radium-223 Versus Radium-223 in Men with Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE). Eur Urol Ma H, Zhang L. PMID: 42336727 [PubMed - as supplied by publisher]
	MRI-targeted versus systematic needle core biopsies in prostate cancer: a patient-based analysis of potential diagnostic and biologic underestimation. J Clin Pathol Saeed F, Osunkoya AO. PMID: 42336636 [PubMed - as supplied by publisher]
	A Pilot Study of Ex-vivo High Frequency Ultrasound and Core Needle Biopsy to Improve Clinical Tumor Staging of Cancer of the Bladder. Urology Roberson DS, Wang MK, McLeay Ii MT, Wei N, Potretzke T, Gupta S, Cheville JC, Kern R, Lomas D, Mynderse L, Khanna A, Shah P, Tollefson MK, Jeffrey Karnes R, Boorjian SA, Sharma V. PMID: 42336158 [PubMed - as supplied by publisher]
	Spatial architecture contributes to failure of bulk biomarker-guided neoadjuvant immunotherapy selection in bladder cancer: The DUTRENEO study. Cell Rep Med Grande E, Sibai M, Grases D, Andrada E, Reig O, Escobosa M, Azueta A, Castellano D, Puente J, Martínez de Villarreal J, Font A, Alonso-Gordoa T, Benítez R, Moreno-Oya A, Álvarez-Maestro M, Burgos J, Climent MA, Domínguez M, Galván P, Galante I, García JF, Perez E, García Del Muro X, Guerrero-Ramos F, Marqués M, Maroto P, Paramio JM, Pinto A, Prat A, Malats N, Durán I, Porta-Pardo E, Real FX. PMID: 42335902 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 179193

Seite 1 von 8960

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung